Table 2 Clinical Management and Outcomes in Pseudomonas aeruginosa bacteraemia

30-day mortality: n (%)

31 (24.2)

10 (11.0)

21 (56.8)

< 0.001

Intensive care unit admission: n (%)

63 (49.2)

40 (44.0)

23 (62.2)

0.163

Acquisition of PAB: n (%)

0.223

 Community acquired

50 (39.1)

32 (35.2)

18 (48.6)

 Hospital acquired

78 (60.9)

59 (64.8)

19 (51.4)

Length of stay in hospital (days; mean, standard deviation)

15.5, 7.8

16.7, 8.5

12.9, 5.7

0.248

Inappropriate or no antibiotic^a: n (%)

40 (31.3)

24 (26.4)

16 (43.2)

0.060

Inappropriate duration of antibiotic: n (%)

29 (22.7)

4 (4.4)

25 (67.6)

< 0.001

De-escalation to oral antibiotic in a timely manner: n (%)

95 (74.2)

80 (87.9%)

15 (40.5%)

< 0.001

Source of PAB: n (%)

0.786

 Unidentified

41 (32.0)

28 (30.8)

13 (35.1)

 Identified

87 (68.0)

63 (69.2)

24 (64.9)

  Intravascular catheter

32 (25.0)

26 (28.6)

6 (16.2)

  Pulmonary infection

20 (15.6)

11 (12.1)

9 (24.3)

  Urinary tract infection

18 (14.1)

14 (15.4)

4 (10.8)

  Skin and soft tissue infection

13 (10.2)

10 (11.0)

3 (8.1)

  Other

4 (3.1)

2 (2.2)

2 (5.4)

Removal of infected catheter: n (%)

30 (23.4)

25 (27.5)

5 (13.5)

0.049

Surgical intervention for source control: n (%)

21 (16.4)

19 (20.9)

2 (5.4)

0.023